KBGGY vs ROIV
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
KBGGY · KONGSBERG GRUPPEN ASA UNSPON ADS EACH REP 0.50 ORD$17.70 ▼ 1.88%
ROIV · Roivant Sciences$38.88 ▲ 6.17%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- KBGGY +7.7%
- ROIV +8.7%
Head to head
| Metric | KBGGY | ROIV |
|---|---|---|
| Price | $17.70 | $38.88 |
| Change today | ▼ 1.88% | ▲ 6.17% |
| Market cap | $28.09B | $28.08B |
| Return, 3 months | +7.7% | +8.7% |
| Return, year to date | – | +79.2% |
| Return, 1 year | – | +88.6% |
| P/E (TTM) | 52.1 | – |
| P/B | 21.9 | 6.6 |
| P/E percentile vs own 5y | – | 1st |
| Dividend yield | 1.73% | – |
| Revenue growth (YoY, latest qtr) | – | -33.5% |
| Net profit growth (YoY) | – | -6.1% |
| Gross margin | – | 81.2% |
| Operating margin | – | -18,146.1% |
| Net margin | – | -3,535.0% |
| Return on equity | – | -6.2% |
| Analyst target vs. price | – | +24.6% |
| Analyst buy share | – | 82% |
| RSI (14) | 54 | 60 |
| 30-day volatility | 47.5% | 43.7% |
| Max drawdown, 1 year | -14.5% | -20.2% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- KBGGY is the largest of the group by market value.
- ROIV has been the calmest stock over the last 30 days.